Effective therapy of insulinoma by using long-acting somatostatin analogue. A case report and literature review

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 2, 2012, Pages 68-72

  Jawiarczyk, A ^a   Bolanowski, M ^a   Syrycka, J ^a   Bednarek Tupikowska, G ^a   Kauny, M ^a   Koodziejczyk, A ^b   Domosawski, P ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b MILITARY HOSPITAL   (Poland)

Author keywords

diabetes mellitus; insulinoma; lanreotide

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOPEPTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIAZOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; NORADRENALIN; NORMETADRENALIN; SOMATOSTATIN RECEPTOR; THIAZIDE DIURETIC AGENT;

ADENOMA; AGED; AMNESIA; ARTERIOGRAPHY; ARTICLE; BLOOD PRESSURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HISTOLOGY; HUMAN; HYPERTENSION; HYPOGLYCEMIA; HYPOGLYCEMIC COMA; INSULIN BLOOD LEVEL; INSULINOMA; PANCREAS SURGERY; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SPLEEN ARTERY; URINALYSIS; WEAKNESS; WEIGHT GAIN;

ANTINEOPLASTIC AGENTS, HORMONAL; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; INSULINOMA; MIDDLE AGED; PANCREATIC NEOPLASMS; SOMATOSTATIN; TREATMENT OUTCOME;

EID: 84856827325     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0031-1287792     Document Type: Article

References (18)

1. Berends F J, Cuesta M A, Kazemier G et al. Laparoscopic detection and resection of insulinomas. Surgery: 2000; 128 386 391
2. Bertherat J, Tenenbaum F, Perlemoine K et al. Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: An in vivo and in vitro study. J Clin Endocrinol Metab: 2003; 88 5353 5360 (Pubitemid 37455411)
3. Caron P, Cogne M, Raingeard I et al. Effectiveness and tolerability of: 3-year Lanreotide Autogel treatment in patients with acromegaly. Clin Endocrinol: 2006; 64 209 214
4. de Herder W W, Kwekkeboom D J, Valkeme R et al. Neuroendocrine tumors and somatostatyn: imaging techniques. Neuroendocrinology: 2005; 28 132 136
5. de Herder W W, Niederle B, Scoazec J Y. Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology: 2006; 84 184 188
6. Goode P N, Farndon J R, Anderson J et al. Diazoxide in the management of patients with insulinoma. World J Surg: 1986; 10 586 592 (Pubitemid 16096415)
7. Grant C S. Insulinoma. Best Pract Res Clin Gastroenterol: 2005; 19 783 798 (Pubitemid 41614123)
8. Katabami T, Kato H, Shirai N et al. Successful long-term treatment with once-daily injection of low-dose octreotide in an aged patient with insulinoma. Endocr J: 2005; 52 629 634 (Pubitemid 41609055)
9. Kondo T, Tomita S, Adachi H et al. A case of hyperinsulinemia of undetermined origin, successfully treated with long-acting octreotide. Endocr J: 2005; 52 511 517 (Pubitemid 41609037)
10. Lamberts S W, Krenning E P, Reubi J C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev: 1991; 12 450 482
11. Moscetti L, Saltarelli R, Giuliani R et al. Intra-arterial liver chemotherapy and hormone therapy in malignant insulinoma: Case report and review of the literature. Tumori: 2000; 86 475 479 (Pubitemid 32128204)
12. Novotny J, Janku F, Mares P et al. Symptomatic control of hypoglycemia with prednisone in refractory metastatic pancreatic insulinoma. Support Care Cancer: 2005; 13 760 762 (Pubitemid 41435569)
13. Romeo S, Milione M, Gatti A et al. Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2. Horm Res: 2006; 65 120 125
14. Tolis G, Angelopoulos N G, Katounda E et al. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin. Neuroendocrinology: 2006; 83 249 257 (Pubitemid 44578879)
15. Usukura M, Yoneda T, Oda N et al. Medical treatment of benign insulinoma using octreotide LAR: a case report. Endocr J: 2007; 54 95 101 (Pubitemid 46481677)
16. Vezzosi D, Bennet A, Courbon F et al. Short- and long-term somatostatin analogue treatment in patients with hypoglycaemia to endogenous hyperinsulinism. Clin Endocrinol: 2008; 68 904 911 (Pubitemid 351703950)
17. Vezzosi D, Bennet A, Rochaix P et al. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. Eur J Endocrinol: 2005; 152 757 767 (Pubitemid 40744545)
18. Yamada Y, Kagimoto S, Kubota A et al. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem Biophys Res Commun: 1993; 195 844 852 (Pubitemid 23280493)